뎅기열 바이러스 소논문 리포트

소개

"뎅기열 바이러스 소논문 리포트"에 대한 내용입니다.

목차

1. Introduction
2. Virology
3. Epidemiology
4. Clinical Manifestations
5. Diagnosis
6. Treatment
7. Prevention and Control
8. Conclusion
9. 참고문헌

본문내용

Abstract
Dengue virus, a major arboviral pathogen transmitted by Aedes mosquitoes, has rapidly become a global public health concern. This comprehensive report explores various aspects of the Dengue virus, including its virology, epidemiology, clinical manifestations, diagnosis, treatment, prevention, and the broader impact it has on public health systems. Understanding Dengue virus is crucial for effective control and management of this complex and evolving infectious disease.

1. Introduction
Dengue fever, caused by the Dengue virus (DENV), is an emerging infectious disease of great importance. Annually, approximately 400 million dengue cases and 22 000 deaths occur worldwide [1] It is primarily transmitted through the bite of infected Aedes mosquitoes, particularly Aedes aegypti and Aedes albopictus. Dengue virus is a member of the Flavivirus genus within the Flaviviridae family. It is characterized by its genetic diversity

참고자료

· Bhatt, S., Gething, P.W., Brady, O.J., Messina, J.P., Farlow, A.W., Moyes, C.L., et al. 2013. The global distribution and burden of dengue. Nature, 496 (7446): 504–507. doi:10.1038/nature12060. PMID:23563266
· Mustafa, M.S., Rasotgi, V., Jain, S., and Gupta, V. 2015. Discovery of fifth serotype of dengue virus (DENV-5): A new public health dilemma in dengue control. Med. J. Armed Forces India, 71(1): 67–70.
· Cleaves, G. R., and D. T. Dubin. 1979. Methylation status of intracellular dengue type 2 40S RNA. Virolog
· Rice, C. M., E. M. Lenches, S. R. Eddy, S. J. Shin, R. L. Sheets, and J. H. Strauss. 1985. Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution. Science 229:726-733.
· Kostyuchenko, V.A., Chew, P.L., Ng, T.S., and Lok, S.M. 2014. Near-atomic resolution cryo-electron microscopic structure of dengue serotype 4 virus. J. Virol. 88(1): 477–482.
· Ferreira GL. Global dengue epidemiology trends. Rev Inst Med Trop Sao Paulo. 2012;54 (Suppl 18):S5–S6.
· Panacea Biotec. n.d. Epidemiology of Dengue. Available from https://www.panaceabiotec.com/epidemiology-of-dengue [accessed on 26 August 2021].
· Carrington, L.B., and Simmons, C.P. 2014. Human to mosquito transmission of dengue viruses. Front. Immunol. 5: 290. doi:10.3389/fimmu.2014.00290. PMID:24987394
· Centers for Disease Control and Prevention. 2014. CDC - Epidemiology-dengue. Available from https://www.cdc.gov/ dengue/index.html [accessed on 21 August 2020].
· Chen, R., and Vasilakis, N. 2011. Dengue—quo tuet quo vadis. Viruses, 3(9): 1562–1608. doi:10.3390/v3091562. PMID:21994796.
· World Health Organization. Dengue: guidelines for diagnosis, treatment, prevention and control. New edition. Geneva, Switzerland: WHO, 2009.
· Modhiran N, Watterson D, Muller DA, et al. Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity. Sci Transl Med 2015
· Damonte, E.B., Matulewicz, M.C., and Cerezo, A.S. 2004. Sulfated seaweed polysaccharides as antiviral agents. Curr. Med. Chem.
· Talarico, L.B., Pujol, C.A., Zibetti, R.G.M., Faria, P.C.S., Noseda, M.D., Duarte, M.E.R., and Damonte, E.B. 2005. The antiviral activity of sulfated polysaccharides against dengue virus is dependent on virus serotype and host cell
· Patkar, C.G., and Kuhn, R.J. 2006. Development of novel antivirals against flaviviruses. In New Treatment Strategies for Dengue and Other Flaviviral Diseases: Novartis Foundation Symposium, Vol. 277. Edited by G. Bocke and J. Goode. pp. 41–52
· Dolan, P.T., Taguwa, S., Rangel, M.A., Acevedo, A., Hagai, T., Andino, R., and Frydman, J. 2021. Principles of dengue virus evolvability derived from genotype-fitness maps in human and mosquito cells
· Harapan, H., Michie, A., Sasmono, R.T., and Imrie, A. 2020. Dengue: A minireview. Viruses